• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷发菌素和磷胞菌素,细菌产生的新型核苷酸类抗生素。

Fosfadecin and fosfocytocin, new nucleotide antibiotics produced by bacteria.

作者信息

Katayama N, Tsubotani S, Nozaki Y, Harada S, Ono H

机构信息

Microbiology Research Laboratories, Takeda Chemical Industries, Ltd., Osaka, Japan.

出版信息

J Antibiot (Tokyo). 1990 Mar;43(3):238-46. doi: 10.7164/antibiotics.43.238.

DOI:10.7164/antibiotics.43.238
PMID:2182591
Abstract

Two new nucleotide antibiotics, fosfadecin and fosfocytocin, have been isolated from the culture filtrates of Pseudomonas viridiflava PK-5 and Pseudomonas fluorescens PK-52, respectively. These antibiotics were purified by column chromatographies using adsorption, gel filtration and ion exchange resins. On the basis of the spectroscopic and degradation studies, the chemical structures of fosfadecin and fosfocytocin were determined. These antibiotics were either enzymatically or chemically hydrolyzed to generate fosfomycin and a new antibiotic, fosfoxacin, which are also produced in the culture filtrates. They showed antibacterial activity against Gram-positive and Gram-negative bacteria. The antibacterial activity of these nucleotide antibiotics was weaker than that of fosfomycin and fosfoxacin.

摘要

两种新的核苷酸类抗生素,磷霉素胺和磷胞霉素,分别从黄绿假单胞菌PK-5和荧光假单胞菌PK-52的培养滤液中分离得到。这些抗生素通过使用吸附、凝胶过滤和离子交换树脂的柱色谱法进行纯化。基于光谱和降解研究,确定了磷霉素胺和磷胞霉素的化学结构。这些抗生素通过酶解或化学水解生成磷霉素和一种新的抗生素磷呋新霉素,它们也存在于培养滤液中。它们对革兰氏阳性菌和革兰氏阴性菌均表现出抗菌活性。这些核苷酸类抗生素的抗菌活性比磷霉素和磷呋新霉素弱。

相似文献

1
Fosfadecin and fosfocytocin, new nucleotide antibiotics produced by bacteria.磷发菌素和磷胞菌素,细菌产生的新型核苷酸类抗生素。
J Antibiot (Tokyo). 1990 Mar;43(3):238-46. doi: 10.7164/antibiotics.43.238.
2
Sperabillins, new antibacterial antibiotics with potent in vivo activity. Taxonomy, fermentation, isolation and biological activity.斯佩拉比林,具有强大体内活性的新型抗菌抗生素。分类学、发酵、分离及生物活性。
J Antibiot (Tokyo). 1992 Jan;45(1):10-9. doi: 10.7164/antibiotics.45.10.
3
Ferrocins, new iron-containing peptide antibiotics produced by bacteria. Taxonomy, fermentation and biological activity.铁霉素,由细菌产生的新型含铁肽类抗生素。分类学、发酵及生物活性。
J Antibiot (Tokyo). 1993 Jan;46(1):65-70. doi: 10.7164/antibiotics.46.65.
4
Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization.
J Antibiot (Tokyo). 1980 Jan;33(1):13-7. doi: 10.7164/antibiotics.33.13.
5
Cepacin A and cepacin B, two new antibiotics produced by Pseudomonas cepacia.洋葱伯克霍尔德氏菌产生的两种新型抗生素,洋葱菌素A和洋葱菌素B。
J Antibiot (Tokyo). 1984 May;37(5):431-40. doi: 10.7164/antibiotics.37.431.
6
LL-AF283 antibiotics, cyclic biphenyl peptides.LL-AF283抗生素,环状联苯肽。
J Antibiot (Tokyo). 1991 Jun;44(6):674-7. doi: 10.7164/antibiotics.44.674.
7
[Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].磷霉素的细菌学研究。体内外抗菌活性(作者译)
Jpn J Antibiot. 1975 Jun;28(3):320-30.
8
Isolation and characterization of new peptide antibiotics, plusbacins A1-A4 and B1-B4.新型肽类抗生素plusbacins A1 - A4和B1 - B4的分离与特性研究
J Antibiot (Tokyo). 1992 Jun;45(6):817-23. doi: 10.7164/antibiotics.45.817.
9
T1801 A, B, C, and D, new quinone and hydroquinone antibiotics produced by a strain of Pseudomonas.T1801 A、B、C和D,由一株假单胞菌产生的新型醌类和对苯二酚类抗生素。
Biosci Biotechnol Biochem. 1992 Sep;56(9):1439-42. doi: 10.1271/bbb.56.1439.
10
Thiotropocin, a new sulfur-containing 7-membered-ring antibiotic produced by a Pseudomonas sp.噻托罗星,一种由假单胞菌属菌株产生的新型含硫七元环抗生素。
J Antibiot (Tokyo). 1984 Nov;37(11):1294-300. doi: 10.7164/antibiotics.37.1294.

引用本文的文献

1
New Application of Saligenyl Prodrugs Approach for the Delivery of Fosfoxacin Derivatives in Mycobacteria.新型 Saligenyl 前药在分枝杆菌中福多司坦衍生物传递中的应用。
Molecules. 2023 Nov 22;28(23):7713. doi: 10.3390/molecules28237713.
2
Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy.磷霉素在4°C和34°C弹性泵中的稳定性研究:门诊肠外抗生素治疗持续输注使用的技术基础。
Pharmaceutics. 2023 Sep 19;15(9):2347. doi: 10.3390/pharmaceutics15092347.
3
The Multifaceted MEP Pathway: Towards New Therapeutic Perspectives.
MEP 通路的多面性:迈向新的治疗视角。
Molecules. 2023 Feb 1;28(3):1403. doi: 10.3390/molecules28031403.
4
Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities.超过40年的磷霉素药物研究:全面综述与未来机遇
Pharmaceuticals (Basel). 2022 Dec 14;15(12):1553. doi: 10.3390/ph15121553.
5
The intriguing biology and chemistry of fosfomycin: the only marketed phosphonate antibiotic.磷霉素引人入胜的生物学与化学特性:唯一上市的膦酸酯类抗生素。
RSC Adv. 2019 Dec 19;9(72):42204-42218. doi: 10.1039/c9ra08299a. eCollection 2019 Dec 18.
6
Functionalization of α-hydroxyphosphonates as a convenient route to -tosyl-α-aminophosphonates.α-羟基膦酸酯的官能团化:一种合成对甲苯磺酰基-α-氨基膦酸酯的简便方法
RSC Adv. 2018 Mar 27;8(22):11957-11974. doi: 10.1039/c8ra01656a. eCollection 2018 Mar 26.
7
Selective Culture Medium for Screening of Fosfomycin Resistance in .用于筛选磷霉素耐药性的选择性培养基。
J Clin Microbiol. 2022 Jan 19;60(1):e0206321. doi: 10.1128/JCM.02063-21. Epub 2021 Oct 20.
8
Fosfomycin: Mechanism and Resistance.磷霉素:作用机制与耐药性
Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a025262. doi: 10.1101/cshperspect.a025262.
9
Characterization of Two Late-Stage Enzymes Involved in Fosfomycin Biosynthesis in Pseudomonads.假单胞菌中参与磷霉素生物合成的两种晚期酶的特性分析。
ACS Chem Biol. 2017 Feb 17;12(2):456-463. doi: 10.1021/acschembio.6b00939. Epub 2016 Dec 27.
10
Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).通过磷酸脱氧木酮糖还原异构酶基因(dxr)中的突变对抗菌剂磷霉素和FR900098前药产生抗性。
Antimicrob Agents Chemother. 2015 Sep;59(9):5511-9. doi: 10.1128/AAC.00602-15. Epub 2015 Jun 29.